[ad_1]
The newspaper reported "Wall street journal" And other means that "Pfizer" Trips were used "Letter" Prepare the vaccine in advance for rapid distribution once it is approved in the United States.
He was the CEO of"Pfizer" Albert Burla, last month, revealed the strategies the company will adopt to overcome obstacles to its vaccine.
He agreed "Pfizer" You should store your vaccine that contains DNA or part of the genetic code of the virus, at a temperature between minus 70 and minus 80 degrees Celsius.
And during his participation in a seminar organized by the newspaper "The New York Times" American, said Mockery "Pfizer" You can ship the vaccine to most areas of the United States of America in no more than one day.
وأضاف بورلا: "The demand for our vaccine will be very high, but we are confident that the vaccines will be very fast after approval by the US Food and Drug Administration.".
During his speech, Burla addressed a series of technical and logistical aspects related to the property, such as the development of engineers in "Pfizer" For the shipment of preservative boxes, it provides the temperature required to maintain the effectiveness of the vaccine, and contains a GPS system, and an alarm that alerts us in case of any defect in these boxes.
Regarding reject "Pfizer" Obtain government funding within a plan "Rap speed" With the goal of helping to accelerate the production of 300 million doses of the Covid-19 vaccine in the United States by 2021, Burla explained: "He wanted to free our academics from the bureaucracy that often accompanies accepting money from government agencies.".
“>
The two groups said in a statement that they had submitted, on Monday, a request from the European Medicines Agency to “obtain a conditional license to market” their vaccine after tests showed it was 95 percent effective against Covid- 19.
The statement added that the vaccine “will be available in Europe before the end of 2020” if it obtains the necessary license, according to “AFP”.
“Pfizer” and its German partner, “Biontech,” announced a few days ago that the results of the final experiments showed that their vaccine was 95 percent effective in preventing Covid-19 without any safety concerns.
The companies expect the US Food and Drug Administration to grant approval for emergency use in mid-December.
Pfizer said it expects to have 50 million doses of vaccines ready this year, enough to protect 25 million people.
And “Pfizer” has an agreement to sell 100 million doses of its vaccine to the US government, giving it the option to buy an additional 500 million doses. The company is also in talks with other governments, including the European Union, about similar deals.
The two companies’ vaccine uses “mRNA” or “ribonucleic acid” technology, as it programs human cells to produce copies of part of the virus, with the aim of stimulating the immune system to attack if the real virus enters the body. .
The announcement of the license application for the “Pfizer” vaccine against Covid-19 in Europe came after US media reported that the first shipments of the “Pfizer” vaccine arrived in the United States from the company’s laboratory in Belgium.
The Wall Street Journal and other outlets reported that Pfizer was using charter flights to pre-prepare the vaccine for rapid distribution once approved in the United States.
And “Pfizer” CEO Albert Burla revealed last month the strategies the company will adopt to overcome obstacles that stand in the way of its vaccine.
According to “Pfizer”, your vaccine that contains DNA or part of the genetic code of the virus must be stored at a temperature between minus 70 and minus 80 degrees Celsius.
During his participation in a symposium organized by the American newspaper “New York Times”, Burla said that “Pfizer” is able to send the vaccine to most areas of the United States of America in no more than one day.
Burla added: “The demand for our vaccine will be very great, but we are confident that vaccination operations will be very fast after approval by the US Food and Drug Administration.”
During his intervention, Burla addressed a series of technical and logistical aspects related to the property, such as the development of engineers at Pfizer for the shipment of container boxes that provide the temperature required to maintain the effectiveness of the vaccine, they also contain a GPS system and an alarm that alerts us in case of any defect in these boxes.
Regarding Pfizer’s refusal to obtain government funding as part of the “Rapid” plan to help accelerate the production of 300 million doses of the Covid-19 vaccine in the United States by 2021, Burla explained: “I wanted to free our scientists from the bureaucracy that usually accompanies them to accept money. ” From government agencies “.
[ad_2]
